Combination Therapy for the Treatment of Diffuse Midline Gliomas

IsraelRecruitingPHASE2

Conditions

Diffuse Intrinsic Pontine Glioma · Diffuse Midline Glioma, H3 K27M-Mutant · Recurrent Diffuse Intrinsic Pontine Glioma · Recurrent Diffuse Midline Glioma, H3 K27M-Mutant · Recurrent WHO Grade III Glioma · WHO Grade III Glioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Alabama at Birmingham, Birmingham, Alabama, United States
Contact: Study coordinator (Girish Dhall, MD) · gdhall@peds.uab.edu
Contact: Principal Investigator (Girish Dhall, MD)
Children's Hospital Los Angeles, Los Angeles, California, United States
Contact: Study coordinator (Tom Davidson, MD) · tdavidson@chla.usc.edu · 323-361-8147
Contact: Principal Investigator (Ashley Margol, MD)
Contact: Principal Investigator (Tom Davidson, MD)
University of California, San Diego / Rady Children's Hospital, San Diego, San Diego, California, United States
Contact: Study coordinator (Megan Paul, MD) · mrpaul@rchsd.org
University of California, San Francisco, San Francisco, California, United States
Contact: Study coordinator (Kelly Hitchner) · PNOC022@ucsf.edu · 415-502-1600
PNOC022@ucsf.edu
Contact: Principal Investigator (Sabine Mueller, MD, PhD)
Children's National Hospital, Washington D.C., District of Columbia, United States
Contact: Study coordinator (Lindsay Kilburn) · LKilburn@childrensnational.org · 202-476-5973
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Ashley S Plant-Fox, MD) · aplant@luriechildrens.org · 312-227-4090
Contact: Principal Investigator (Ashley S Plant-Fox, MD)
Indiana University Riley Children's Hospital, Indianapolis, Indiana, United States
Contact: Study coordinator (Scott Coven, MD) · scoven@iu.edu · 317-944-2143
Contact: Principal Investigator (Scott Coven, MD)
Johns Hopkins University, Baltimore, Maryland, United States
Contact: Study coordinator (Kenneth Cohen, MD) · kcohen@jhmi.edu
Contact: Principal Investigator (Kenneth Cohen, MD)
Dana-Farber Cancer Institute Harvard University, Boston, Massachusetts, United States
Contact: Study coordinator (Susan Chi, MD) · susan_chi@dfci.harvard.edu · 617-632-2291
University of Michigan, Ann Arbor, Michigan, United States
Contact: Study coordinator (Carl Koschmann, MD) · ckoschma@med.umich.edu · 734-615-2736
Contact: Principal Investigator (Andrea Franson, MD)
Contact: Principal Investigator (Carl Koschmann, MD)
Children's Hospital Minnesota, Minneapolis, Minnesota, United States
Contact: Study coordinator (Anne Bendel, MD) · anne.bendel@childrensmn.org · 612-626-2778
Washington University in St. Louis, St Louis, Missouri, United States
Contact: Study coordinator (Mohamed Shebl Abdelbaki, MD) · MohamedA@wustl.edu;
Hackensack Meridian Health, Hackensack, New Jersey, United States
Contact: Study coordinator (Derek Hanson, MD) · derek.hanson@hmhn.org
Contact: Principal Investigator (Derek Hanson, MD)
New York University, New York, New York, United States
Contact: Study coordinator (Jessica Clymer, MD) · jessica.clymer@nyulangone.org
Duke University, Durham, North Carolina, United States
Contact: Study coordinator (Laura Gorski, BSN, RN, CPN) · dukebrain1@dm.duke.edu · 919-684-5301
Contact: Study coordinator (Kate Hogan, MS) · dukebrain1@dm.duke.edu · 919-684-5301
Contact: Principal Investigator (Daniel Landi, MD)
Nationwide Children's Hospital, Columbus, Ohio, United States
Contact: Study coordinator (Margot Lazow, MD) · margot.lazow@nationwidechildrens.org · 614-722-3250
Contact: Principal Investigator (Margot Lazow, MD)
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Cassie Kline, MD) · klinec@chop.edu
Contact: Principal Investigator (Cassie Kline, MD)
University of Utah, Salt Lake City, Utah, United States
Contact: Study coordinator (Nicholas Whipple, MD, MPH) · Nicholas.whipple@hsc.utah.edu · 801-662-4700
Seattle Children's Hospital, Seattle, Washington, United States
Contact: Study coordinator (Erin Crotty, MD) · Erin.crotty@seattlechildrens.org · 206-987-2106
John Hunter Children's Hospital, New Lambton Heights, New South Wales, Australia
Contact: Study coordinator (Frank Alvaro) · frank.alvaro@health.nsw.gov.au
The Children's Hospital at Westmead, Westmead, New South Wales, Australia
Contact: Study coordinator (Regienald Gayaman) · regienald.gayaman@health.nsw.gov.au · +61 2 9845 0925
Contact: Principal Investigator (Dinisha Govender, MBChB, FRACP)
Queensland Children's Hospital, South Brisbane, Queensland, Australia
Contact: Study coordinator (Wayne Nicholls) · wayne.nicholls@health.qld.gov.au
Contact: Principal Investigator (Wayne Nicholls, MBBS)
Monash Children's Hospital, Clayton, Victoria, Australia
Contact: Study coordinator (Paul Wood, BPharm, MS, MBBS, FRACP) · paul.wood@monashhealth.org.au · 61 3 8572 3000
The Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia
Contact: Study coordinator (Dong Anh Khuong Quang) · donganh.khuongquang@rch.org.au
Perth Children's Hospital, Nedlands, Washington, Australia
Contact: Study coordinator (Santosh Valvi, FRACP, MD, MSc) · Santosh.Valvi@health.wa.gov.au · 61 8 6456 2222
Women and Children's Hospital, Adelaide, Australia
Contact: Study coordinator (Jordan Hansford)
Sydney Children's Hospital, Sydney, Australia
Contact: Study coordinator (Marion Mateos, MD) · m.mateos@unsw.edu.au
Sheba Medical Center, Tel Litwinsky, Ramat Gan, Israel
Contact: Study coordinator (Michal Yalon)
Shaare Zedek Medical Center, Jerusalem, Israel
Contact: Study coordinator (Iris Fried) · Irisf@szmc.org.il
Princess Maxima Center, Utrecht, Netherlands
Starship Children's Hospital, Auckland, New Zealand
Contact: Study coordinator (Karen Tsui Tsui, MBChB, Dip Paed, FRACP) · karent@adhb.govt.nz · +64 9 367 0000
The University Children's Hospital in Zurich, Zurich, Switzerland
Contact: Study coordinator (Nicolas Gerber, MD) · glioma@kispi.uzh.ch · +41 44 249 63 50
Contact: Study coordinator (Ana Guerreiro Stuecklin, MD, PhD) · glioma@kispi.uzh.ch · +41 44 266 3117

Study leads

Sabine Mueller, MD, PhD
Principal Investigator
University of California, San Francisco

View source on ClinicalTrials.gov Contact study team (email)